4.4 Article

p53 induces transcriptional and translational programs to suppress cell proliferation and growth

期刊

GENOME BIOLOGY
卷 14, 期 4, 页码 -

出版社

BMC
DOI: 10.1186/gb-2013-14-4-r32

关键词

cell proliferation and growth; mTOR; p53 signaling; ribosome profiling; senescence; translation regulation

资金

  1. VICI-NOW (Nederlandse Organisatie voor Wetenschappelijk Onderzoek)
  2. ERC (European Research Council)
  3. KWF (Dutch Cancer Foundation)
  4. CBG (Centre for Biomedical Genetics)

向作者/读者索取更多资源

Background: Cell growth and proliferation are tightly connected to ensure that appropriately sized daughter cells are generated following mitosis. Energy stress blocks cell growth and proliferation, a critical response for survival under extreme conditions. Excessive oncogenic stress leads to p53 activation and the induction of senescence, an irreversible state of cell-cycle arrest and a critical component in the suppression of tumorigenesis. Nutrient-sensing and mitogenic cues converge on a major signaling node, which regulates the activity of the mTOR kinase. Although transcriptional responses to energy and oncogenic stresses have been examined by many gene-expression experiments, a global exploration of the modulation of mRNA translation in response to these conditions is lacking. Results: We combine RNA sequencing and ribosomal profiling analyses to systematically delineate modes of transcriptional and translational regulation induced in response to conditions of limited energy, oncogenic stress and cellular transformation. We detect a key role for mTOR and p53 in these distinct physiological states, and provide the first genome-wide demonstration that p53 activation results in mTOR inhibition and a consequent global repression of protein translation. We confirm the role of the direct p53 target genes Sestrin1 and Sestrin2 in this response, as part of the broad modulation of gene expression induced by p53 activation. Conclusions: We delineate a bimodal tumor-suppressive regulatory program activated by p53, in which cell-cycle arrest is imposed mainly at the transcriptional level, whereas cell growth inhibition is enforced by global repression of the translation machinery.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, Research & Experimental

Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes

Michael T. Meister, Marian J. A. Groot Koerkamp, Terezinha de Souza, Willemijn B. Breunis, Ewa Frazer-Mendelewska, Mariel Brok, Jeff DeMartino, Freek Manders, Camilla Calandrini, Hinri H. D. Kerstens, Alex Janse, M. Emmy M. Dolman, Selma Eising, Karin P. S. Langenberg, Marc van Tuil, Rutger R. G. Knops, Sheila Terwisscha van Scheltinga, Laura S. Hiemcke-Jiwa, Uta Flucke, Johannes H. M. Merks, Max M. van Noesel, Bastiaan B. J. Tops, Jayne Y. Hehir-Kwa, Patrick Kemmeren, Jan J. Molenaar, Marc van de Wetering, Ruben van Boxtel, Jarno Drost, Frank C. P. Holstege

Summary: This study successfully generated a collection of 19 pediatric RMS tumor organoid models, including all major subtypes. For aggressive tumors, the models can be established within a relatively short period of time and utilized for personalized drug screening. The models closely resemble the original tumors and maintain genetic stability over extended culture periods.

EMBO MOLECULAR MEDICINE (2022)

Article Biochemistry & Molecular Biology

Alternative cleavage and polyadenylation generates downstream uncapped RNA isoforms with translation potential

Yuval Malka, Ferhat Alkan, Shinyeong Ju, Pierre-Rene Korner, Abhijeet Pataskar, Eldad Shulman, Fabricio Loayza-Puch, Julien Champagne, Casper Wenzel, William James Faller, Ran Elkon, Cheolju Lee, Reuven Agami

Summary: The use of alternative promoters, splicing, and cleavage and polyadenylation (APA) generates uncapped and polyadenylated transcripts (5' UPTs) that expand transcriptome diversity. These transcripts resist degradation due to structured RNA and N6-methyladenosine modification. 5' UPTs appear downstream of APA sites and are induced upon APA activation.

MOLECULAR CELL (2022)

Article Oncology

Molecular Characterization Reveals Subclasses of 1q Gain in Intermediate Risk Wilms Tumors

Ianthe A. E. M. van Belzen, Marc van Tuil, Shashi Badloe, Eric Strengman, Alex Janse, Eugene T. P. Verwiel, Douwe F. M. van der Leest, Sam de Vos, John Baker-Hernandez, Alissa Groenendijk, Ronald de Krijger, Hindrik H. D. Kerstens, Jarno Drost, Marry M. Van den Heuvel-Eibrink, Bastiaan B. J. Tops, Frank C. P. Holstege, Patrick Kemmeren, Jayne Y. Hehir-Kwa

Summary: This study investigates the mutational mechanisms and functional effects of chromosomal alterations in Wilms tumors (WTs), particularly the 1q gain. By integrating genomic data and expression data, subgroups of tumors with 1q gain were identified, and differences in functional effects and mutational mechanisms were observed. The findings suggest that incorporating expression data could improve the clinical utility of 1q gain in risk stratification.

CANCERS (2022)

Editorial Material Oncology

Roles of eIF5A in the immunosurveillance of cellular senescence

Xiangli Jiang, Fabricio Loayza-Puch

CANCER BIOLOGY & MEDICINE (2022)

Article Biology

Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRAS(G12D) glycolytic colorectal tumors

Marlies C. Ludikhuize, Sira Gevers, Nguyen T. B. Nguyen, Maaike Meerlo, S. Khadijeh Shafiei Roudbari, M. Can Gulersonmez, Edwin C. A. Stigter, Jarno Drost, Hans Clevers, Boudewijn M. T. Burgering, Maria J. Rodriguez Colman

Summary: In p53-deficient colorectal cancer organoids, 5-fluorouracil induces pyrimidine imbalance, which leads to DNA damage and cell death. Rewiring glucose metabolism through PDK inhibition by DCA enhances 5-FU toxicity in glycolytic p53-deficient organoids. This has important implications for improving chemotherapy strategies for colorectal cancer, and p53 emerges as a key factor in determining the response to 5-FU.

COMMUNICATIONS BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Metabolic Activation of Benzo[a]pyrene by Human Tissue Organoid Cultures

Angela L. Caipa L. Garcia, Jill E. E. Kucab, Halh Al-Serori, Rebekah S. S. Beck, Franziska Fischer, Matthias Hufnagel, Andrea Hartwig, Andrew Floeder, Silvia Balbo, Hayley Francies, Mathew Garnett, Meritxell Huch, Jarno Drost, Matthias Zilbauer, Volker M. M. Arlt, David H. H. Phillips

Summary: Human organoids derived from different tissues have the ability to metabolize the environmental carcinogen benzo[a]pyrene. The response and metabolite formation of the organoids varied between tissue types. This study demonstrates the potential of organoids for studying environmental carcinogenesis and genetic toxicology.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Proteome diversification by mRNA translation in cancer

Adva Kochavi, Domenica Lovecchio, William James Faller, Reuven Agami

Summary: mRNA translation is altered in cancer to promote cancer development and can be targeted for immunotherapy. Ribosome heterogeneity and alternative responses to nutrient shortages in cancer cells may result in therapeutic targets such as cancer-specific peptides. This review will assess the underlying mechanisms of proteome diversification in cancer cells due to alterations in mRNA translation.

MOLECULAR CELL (2023)

Review Oncology

The tumor microenvironment and immune targeting therapy in pediatric renal tumors

Amy B. Hont, Benoit Dumont, Kathryn S. Sutton, John Anderson, Alex Kentsis, Jarno Drost, Andrew L. Hong, Arnauld Verschuur

Summary: This review summarizes the role of various immunomodulating elements in the tumor microenvironment of pediatric renal tumors, including Wilms tumor. It discusses the roles of innate and adaptive immune cells, as well as immunomodulatory cytokines and proteins. The expression and predictive role of checkpoint modulators like PD-L1 and immunomodulating proteins like glypican-3, B7-H3, COX-2 are highlighted, with a focus on potential therapeutic innovations. Preclinical models and clinical trials of immunomodulating strategies, such as monoclonal antibodies and CAR-T cells, for relapsed/refractory/progressive pediatric renal tumors are also discussed.

PEDIATRIC BLOOD & CANCER (2023)

Article Oncology

ABPEPserver: a web application for documentation and analysis of substitutants

Abhijeet Pataskar, Jasmine Montenegro Navarro, Reuven Agami

Summary: ABPEPserver is an online database and analytical platform that visualizes a large-scale tumor proteomics analysis of Substitutant expression across eight tumor types sourced from the CPTAC database. It offers gene-association signature analysis of Substitutant peptides, comparison of enrichment between tumor and tumor-adjacent normal tissues, and a list of candidate peptides for immunotherapy design.

BMC CANCER (2023)

Article Cell Biology

Oncogenic signaling is coupled to colorectal cancer cell differentiation state

Thomas Sell, Christian Klotz, Matthias M. Fischer, Rosario Astaburuaga-Garcia, Susanne Krug, Jarno Drost, Hans Clevers, Christine Sers, Markus Morkel, Nils Bluethgen

Summary: Colorectal cancer progression is closely related to deregulation of intestinal differentiation trajectory. The sequential mutations of APC, KRAS, TP53, and SMAD4 enable oncogenic signaling and establish cancer hallmarks. Mass cytometry of isogenic human colon and patient-derived cancer organoids reveals a differentiation axis from normal to cancer states, shaped by the driver mutations. Cells along this axis can be influenced by subsequent mutations to promote or restrict stem cell properties. Nodes of the cancer cell signaling network remain coupled to the differentiation state. Single-cell RNA sequencing links protein signaling network to transcriptomic states with biological and clinical importance.

JOURNAL OF CELL BIOLOGY (2023)

Review Oncology

Somatic, Genetic and Epigenetic Changes in Nephrogenic Rests and Their Role in the Transformation to Wilms Tumors, a Systematic Review

Tessa Banki, Jarno Drost, Marry M. M. van den Heuvel-Eibrink, Annelies M. C. Mavinkurve-Groothuis, Ronald R. R. de Krijger

Summary: This study reviewed the molecular changes in nephrogenic rests (NR), which are believed to be precursor lesions of Wilms tumors (WT), the most common malignant childhood renal tumors, from 1990 to 2022. The findings showed that two genes, WT1 and WTX, and two chromosomal regions, 11p13 and 11p15, were mutated or showed loss of imprinting in both NR and WT, suggesting their potential roles in early tumorigenesis.

CANCERS (2023)

Editorial Material Oncology

Breast Cancer Metastatic Progression Requires mRNA Posttranscriptional Suppression

Cinthia Claudia Amaya Ramirez, Fabricio Loayza-Puch

CANCER RESEARCH (2023)

Review Urology & Nephrology

Hallmark discoveries in the biology of Wilms tumour

Daniela Perotti, Richard D. Williams, Jenny Wegert, Jack Brzezinski, Mariana Maschietto, Sara Ciceri, David Gisselsson, Samantha Gadd, Amy L. Walz, Rhoikos Furtwaengler, Jarno Drost, Reem Al-Saadi, Nicholas Evageliou, Saskia L. Gooskens, Andrew L. Hong, Andrew J. Murphy, Michael V. Ortiz, Maureen J. O'Sullivan, Elizabeth A. Mullen, Marry M. van den Heuvel-eibrink, Conrad V. Fernandez, Norbert Graf, Paul E. Grundy, James I. Geller, Jeffrey S. Dome, Elizabeth J. Perlman, Manfred Gessler, Vicki Huff, Kathy Pritchard-Jones

Summary: The study of Wilms tumour has significantly advanced our understanding of its biology and genetics, with the development of the 'two-hit' model of tumour development and the discovery of the genetic landscape of the tumour. Efforts have also been made to find prognostic biomarkers and develop preclinical models. However, there are still many unanswered questions, such as the molecular understanding of relapse and the origins of bilateral Wilms tumour.

NATURE REVIEWS UROLOGY (2023)

Meeting Abstract Oncology

TO SCREEN OR NOT TO SCREEN: THAT'S THE QUESTION! - EXPLORING DRUG SENSITIVITY PROFILING IN THE PRECISION MEDICINE PROGRAM ITHER

Karin Langenberg, Eleonora Looze, Michael Meister, Camilla Calandrini, Femke Ringnalda, Natasha Van Eijkelenburg, Miranda Dierselhuis, Ronald De Krijger, Kimberley Ober, Linda Schild, Jarno Drost, Marc Van DeWetering, Sander Van Hooff, Selma Eising, Jan Koster, Max M. Van Noesel, Jan Molenaar

PEDIATRIC BLOOD & CANCER (2022)

Article Endocrinology & Metabolism

Cancer-associated fibroblasts require proline synthesis by PYCR1 for the deposition of pro-tumorigenic extracellular matrix

Emily J. Kay, Karla Paterson, Carla Riero-Domingo, David Sumpton, J. Henry M. Dabritz, Saverio Tardito, Claudia Boldrini, Juan R. Hernandez-Fernaud, Dimitris Athineos, Sandeep Dhayade, Ekaterina Stepanova, Enio Gjerga, Lisa J. Neilson, Sergio Lilla, Ann Hedley, Grigorios Koulouras, Grace McGregor, Craig Jamieson, Radia Marie Johnson, Morag Park, Kristina Kirschner, Crispin Miller, Jurre J. Kamphorst, Fabricio Loayza-Puch, Julio Saez-Rodriguez, Massimiliano Mazzone, Karen Blyth, Michele Zagnoni, Sara Zanivan

Summary: The study reveals that the newly synthesized proline in CAFs promotes the production of tumor collagen in breast cancer xenografts, and reducing PYCR1 levels can inhibit tumor growth and metastasis. Additionally, the synthesis of collagen and proline in CAFs is epigenetically regulated by increased pyruvate dehydrogenase-derived acetyl-CoA levels.

NATURE METABOLISM (2022)

暂无数据